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The literature available regarding SCT in FA patients with renal impairment is scarce. Heitink-Polle et al. 2 recently reported a successful allo-SCT in a patient with FA and renal failure using a conditioning regimen of fludarabine and thoraco-abdominal irradiation, and we would like to describe here an alternative conditioning regimen without the use of radiation in a 2-year-old girl with confirmed FA who underwent matched related SCT at our institution. Before SCT, the patient was blood-and plt transfusion-dependent. In addition, she had evidence of chronic renal failure and was followed by the nephrology team; her renal failure was because of renal dysplasia secondary to left vesicoureteral reflux. On account of her increased requirements of plt and blood transfusions, a decision was made to proceed with SCT as at that point her renal failure was not deemed severe enough to warrant a renal transplant. A pre-SCT BM biopsy confirmed aplasia and showed no evidence of myelodysplasia, and no chromosomal abnormalities were noted on the cytogenetic analysis.
At the time of SCT, the patient's serum creatinine was 189 mmol/l and the estimated calculated creatinine clearance (CrCl) was 17 ml/min per 1.73 m /kg recipient weight. The post-SCT course was complicated by hypertension, which was managed with the appropriate antihypertensive medications. She also developed sepsis with Klebsiella pneumonia and streptococcus species and was treated with i.v. antibiotics. No significant mucositis or liver dysfunction was noted and the patient maintained a serum creatinine level in the range of 91-211 mmol/l throughout her admission.
G-CSF was administered post-SCT, and the patient engrafted (ANC 4500 Â 10 6 /l) on day þ 14, and had plt engraftment (420 Â 10 9 /l) on day þ 65. The chimerism studies were performed on day þ 28 and showed 100% donor myeloid and lymphoid engraftment. Her renal laboratory profile has remained within the same pre-SCT range. On day þ 35, she developed bloody diarrhea; a rectal biopsy confirmed grade II acute GVHD of the gut. She was treated with steroids 2 mg/kg/day, responded promptly to therapy and is now symptom-free.
Many cases of uneventful allo-SCT have been reported previously in patients with renal impairment, usually after reducing the doses of the agents used in the conditioning. [3] [4] [5] In FA patients, the problem is compounded, however, as the conditioning regimens used in their preparation already consist of reduced doses of chemo or radiation because of their underlying genetic defect, 6 and because further reductions may potentially lead to graft failure.
Heitink-Polle et al. successfully used reduced-dose fludarabine in addition to radiation to avoid the use of cytoxan, but although renal impairment may affect the clearance of CY, 7 reduced doses of CY have been previously used in preparing patients with chronic renal failure for allo-SCT in patients. 3, 4 Ballester et al. 5 even used full doses of CY in a cohort of patients with multiple myeloma and renal failure who underwent auto-SCT with no unusual adverse affects. Furthermore, the use of radiation has been associated with carcinogenic effects in patients undergoing SCT. We conclude, therefore, that conditioning with chemotherapy alone for allo-SCT is feasible in FA patients suffering from renal failure. When possible, SCT should probably be performed before the need for a renal transplant becomes pressing. Miano et al. 9 reported a successful outcome in an FA patient who underwent BMT first and underwent a renal transplant 3.5 years later. In contrast, Barraclough et al. 10 reported a patient with FA who had a renal transplant followed 2 years later by an allo-SCT. The patient subsequently suffered from renal graft rejection, presumably through a graft-vs-graft mechanism. 
